Avior Wealth Management’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Avior Wealth Management’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-100	Closed	-$1.62K	–	914
2019 Q2	$1K	Hold	100	–	–	﹤0.01%	832
2019 Q1	$0	Hold	100	–	–	﹤0.01%	762
2018 Q4	$0	Hold	100	–	–	﹤0.01%	787
2018 Q3	$2K	Hold	100	–	–	﹤0.01%	696
2018 Q2	$3K	Hold	100	–	–	﹤0.01%	707
2018 Q1	$3K	Sell	100 -400	-80%	-$12K	﹤0.01%	685
2017 Q4	$14K	Hold	500	–	–	﹤0.01%	572
2017 Q3	$12K	Buy	+500	New	+$11.9K	﹤0.01%	322

Other funds holding DOVA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Avior Wealth Management's DOVA Position: Q3 2019 in Review

Avior Wealth Management sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q3 2019, closing a stake of 100 shares — an estimated $1.62K sold.

Avior Wealth Management first reported a position in DOVA in Q3 2017 and held it in 8 quarters. The position peaked at $14K in Q4 2017. 72 funds tracked by Wall St. Rank hold DOVA as of Q3 2019.

Avior Wealth Management reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Avior Wealth Management sold 100 Dova Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $1.62K.
Avior Wealth Management first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 8 quarters.
Avior Wealth Management's Dova Pharmaceuticals, Inc. Common Stock position peaked at $14K in Q4 2017.
72 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Avior Wealth Management's 13F filing for Q3 2019, filed 9 Oct 2019.